7.20
+0.25
+(3.60%)
At close: 8:13:04 AM GMT+2
Loading Chart for 0K91.DU
- Previous Close
6.95 - Open
7.20 - Bid 7.20 x --
- Ask 7.45 x --
- Day's Range
7.20 - 7.20 - 52 Week Range
1.15 - 75.07 - Volume
0 - Avg. Volume
3 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date May 12, 2025 - May 16, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: 0K91.DU
View MorePerformance Overview: 0K91.DU
Trailing total returns as of 4/2/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
0K91.DU
73.08%
S&P/TSX Composite index (^GSPTSE)
2.79%
1-Year Return
0K91.DU
523.38%
S&P/TSX Composite index (^GSPTSE)
14.64%
3-Year Return
0K91.DU
830.23%
S&P/TSX Composite index (^GSPTSE)
15.28%
5-Year Return
0K91.DU
99.89%
S&P/TSX Composite index (^GSPTSE)
93.22%
Compare To: 0K91.DU
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
7.20
+3.60%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
15.29
0.00%
Mkt Cap 17.52B
Industry Drug Manufacturers—Specialty & Generic
Statistics: 0K91.DU
View MoreValuation Measures
As of 4/1/2025
Market Cap
14.49M
Enterprise Value
8.72M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
0.89
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--